These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 19640507)

  • 1. Effect of a history of major depressive disorder on smoking-induced dopamine release.
    Brody AL; Olmstead RE; Abrams AL; Costello MR; Khan A; Kozman D; Saxena S; Farahi J; London ED; Mandelkern MA
    Biol Psychiatry; 2009 Nov; 66(9):898-901. PubMed ID: 19640507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ventral striatal dopamine release in response to smoking a regular vs a denicotinized cigarette.
    Brody AL; Mandelkern MA; Olmstead RE; Allen-Martinez Z; Scheibal D; Abrams AL; Costello MR; Farahi J; Saxena S; Monterosso J; London ED
    Neuropsychopharmacology; 2009 Jan; 34(2):282-9. PubMed ID: 18563061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smoking-induced change in intrasynaptic dopamine concentration: effect of treatment for Tobacco Dependence.
    Brody AL; London ED; Olmstead RE; Allen-Martinez Z; Shulenberger S; Costello MR; Abrams AL; Scheibal D; Farahi J; Shoptaw S; Mandelkern MA
    Psychiatry Res; 2010 Sep; 183(3):218-24. PubMed ID: 20682457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smoking-induced ventral striatum dopamine release.
    Brody AL; Olmstead RE; London ED; Farahi J; Meyer JH; Grossman P; Lee GS; Huang J; Hahn EL; Mandelkern MA
    Am J Psychiatry; 2004 Jul; 161(7):1211-8. PubMed ID: 15229053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopaminergic activity in depressed smokers: a positron emission tomography study.
    Busto UE; Redden L; Mayberg H; Kapur S; Houle S; Zawertailo LA
    Synapse; 2009 Aug; 63(8):681-9. PubMed ID: 19360907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene variants of brain dopamine pathways and smoking-induced dopamine release in the ventral caudate/nucleus accumbens.
    Brody AL; Mandelkern MA; Olmstead RE; Scheibal D; Hahn E; Shiraga S; Zamora-Paja E; Farahi J; Saxena S; London ED; McCracken JT
    Arch Gen Psychiatry; 2006 Jul; 63(7):808-16. PubMed ID: 16818870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Striatal dopamine D2/3 receptor-mediated neurotransmission in major depression: Implications for anhedonia, anxiety and treatment response.
    Peciña M; Sikora M; Avery ET; Heffernan J; Peciña S; Mickey BJ; Zubieta JK
    Eur Neuropsychopharmacol; 2017 Oct; 27(10):977-986. PubMed ID: 28870407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine Release in Antidepressant-Naive Major Depressive Disorder: A Multimodal [
    Schneier FR; Slifstein M; Whitton AE; Pizzagalli DA; Reinen J; McGrath PJ; Iosifescu DV; Abi-Dargham A
    Biol Psychiatry; 2018 Oct; 84(8):563-573. PubMed ID: 30041971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cigarette smoking on cortical thickness in major depressive disorder.
    Zorlu N; Cropley VL; Zorlu PK; Delibas DH; Adibelli ZH; Baskin EP; Esen ÖS; Bora E; Pantelis C
    J Psychiatr Res; 2017 Jan; 84():1-8. PubMed ID: 27669406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The hedonic response to cigarette smoking is proportional to dopamine release in the human striatum as measured by positron emission tomography and [11C]raclopride.
    Barrett SP; Boileau I; Okker J; Pihl RO; Dagher A
    Synapse; 2004 Nov; 54(2):65-71. PubMed ID: 15352131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Negative association of pretreatment cigarette use with smoking-induced striatal dopamine release in smokers receiving bupropion treatment.
    Weinstein AM; Freedman N; Greif J; Yemini Z; Mishani E; London E; Chisin R; Bocher M
    Am J Addict; 2016 Sep; 25(6):486-92. PubMed ID: 27467186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smoking modulation of mu-opioid and dopamine D2 receptor-mediated neurotransmission in humans.
    Scott DJ; Domino EF; Heitzeg MM; Koeppe RA; Ni L; Guthrie S; Zubieta JK
    Neuropsychopharmacology; 2007 Feb; 32(2):450-7. PubMed ID: 17091130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DRD2/ANKK1 Taq1A polymorphism (rs1800497) has opposing effects on D2/3 receptor binding in healthy controls and patients with major depressive disorder.
    Savitz J; Hodgkinson CA; Martin-Soelch C; Shen PH; Szczepanik J; Nugent AC; Herscovitch P; Grace AA; Goldman D; Drevets WC
    Int J Neuropsychopharmacol; 2013 Oct; 16(9):2095-101. PubMed ID: 23683269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute anxiety disorder, major depressive disorder, bipolar disorder and schizophrenia are related to different patterns of nigrostriatal and mesolimbic dopamine dysfunction.
    Nikolaus S; Mamlins E; Hautzel H; Müller HW
    Rev Neurosci; 2019 May; 30(4):381-426. PubMed ID: 30269107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Striatal dopamine deficits predict reductions in striatal functional connectivity in major depression: a concurrent
    Hamilton JP; Sacchet MD; Hjørnevik T; Chin FT; Shen B; Kämpe R; Park JH; Knutson BD; Williams LM; Borg N; Zaharchuk G; Camacho MC; Mackey S; Heilig M; Drevets WC; Glover GH; Gambhir SS; Gotlib IH
    Transl Psychiatry; 2018 Nov; 8(1):264. PubMed ID: 30504860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine type-1 receptor binding in major depressive disorder assessed using positron emission tomography and [11C]NNC-112.
    Cannon DM; Klaver JM; Peck SA; Rallis-Voak D; Erickson K; Drevets WC
    Neuropsychopharmacology; 2009 Apr; 34(5):1277-87. PubMed ID: 18946469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Striatal dopamine D2 receptors in medication-naive patients with major depressive disorder as assessed with [11C]raclopride PET.
    Hirvonen J; Karlsson H; Kajander J; Markkula J; Rasi-Hakala H; Någren K; Salminen JK; Hietala J
    Psychopharmacology (Berl); 2008 May; 197(4):581-90. PubMed ID: 18251011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measuring cigarette smoking-induced cortical dopamine release: A [¹¹C]FLB-457 PET study.
    Wing VC; Payer DE; Houle S; George TP; Boileau I
    Neuropsychopharmacology; 2015 May; 40(6):1417-27. PubMed ID: 25502631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of amphetamine-induced dopamine release by group II metabotropic glutamate receptor agonist LY354740 in non-human primates studied with positron emission tomography.
    van Berckel BN; Kegeles LS; Waterhouse R; Guo N; Hwang DR; Huang Y; Narendran R; Van Heertum R; Laruelle M
    Neuropsychopharmacology; 2006 May; 31(5):967-77. PubMed ID: 16177807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Voxelwise lp-ntPET for detecting localized, transient dopamine release of unknown timing: sensitivity analysis and application to cigarette smoking in the PET scanner.
    Kim SJ; Sullivan JM; Wang S; Cosgrove KP; Morris ED
    Hum Brain Mapp; 2014 Sep; 35(9):4876-91. PubMed ID: 24700424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.